Company news

Syros Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital

July 16, 2025

Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration

February 28, 2025

Calls

The 5 newest of 15 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.